Cervomed featured in fortune for advances in the treatment of dementia with lewy bodies

Boston, aug. 22, 2024 (globe newswire) -- cervomed inc. (nasdaq: crvo), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced its recent feature in fortune magazine.

CRVO Ratings Summary

CRVO Quant Ranking